Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum.

Saved in:
Bibliographic Details
Title: Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum.
Authors: Dorbala S; Brigham and Women's Hospital, Boston, Massachusetts, USA., Adigun R; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Alexander KM; Stanford University, Stanford, California, USA., Brambatti M; Ionis Pharmaceuticals, Inc, Carlsbad, California, USA., Cuddy SAM; Brigham and Women's Hospital, Boston, Massachusetts, USA., Dispenzieri A; Mayo Clinic, Rochester, Minnesota, USA., Dunnmon P; Janssen Research and Development, Raritan, New Jersey, USA., Emdin M; Scuola Superiore Sant'Anna, Fondazione G. Monasterio, Pisa, Italy., Abou Ezzeddine OF; Mayo Clinic, Rochester, Minnesota, USA., Falk RH; Harvard Medical School, Boston, Massachusetts, USA., Fontana M; University College London, London, England, United Kingdom., Grodin JL; University of Texas Southwestern Medical Center, Dallas, Texas, USA., Guthrie S; Attralus, Inc, San Francisco, California, USA., Jerosch-Herold M; Brigham and Women's Hospital, Boston, Massachusetts, USA., Hofling AA; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Hsu K; Amyloidosis Research Consortium, Newton, Massachusetts, USA., Lin G; Mayo Clinic, Rochester, Minnesota, USA., Masri A; Oregon Health and Science University, Portland, Oregon, USA., Maurer MS; Columbia University Irving Medical Center, New York, New York, USA., Mittmann C; Federal Institute for Drugs and Medical Devices, Bonn, Germany., Prasad K; UK Medicines and Healthcare Products Regulatory Agency, London, England, United Kingdom., Quarta CC; Alexion Pharmaceuticals, Inc, Boston, Massachusetts, USA., Race JM; Agence nationale de sécurité du médicament et des produits de santés, Saint Denis, France., Rajendran JG; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Ruberg FL; Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA., Sachdev V; National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA., Sanchorawala V; Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA., Signorovitch J; Analysis Group, Boston, Massachusetts, USA., Sirac C; University of Limoges, Limoges, France., Soman P; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Sorensen J; Uppsala University, Uppsala, Sweden., Sperry BW; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA., Stephens AW; Life Molecular Imaging, Berlin, Germany., Stockbridge NL; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Vest J; Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA., Wall JS; University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, USA., Wechalekar A; University College London, London, England, United Kingdom., Welsh C; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Lousada I; Amyloidosis Research Consortium, Newton, Massachusetts, USA. Electronic address: ILousada@arci.org.
Source: JACC. Cardiovascular imaging [JACC Cardiovasc Imaging] 2025 May; Vol. 18 (5), pp. 602-617. Date of Electronic Publication: 2025 Feb 21.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101467978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-7591 (Electronic) Linking ISSN: 18767591 NLM ISO Abbreviation: JACC Cardiovasc Imaging Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1876-7591
DOI:10.1016/j.jcmg.2024.11.003